Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis

被引：0
|
作者：
P Guglielmelli
F Biamonte
A Spolverini
L Pieri
A Isgrò
E Antonioli
A Pancrazzi
A Bosi
G Barosi
A M Vannucchi
机构：
[1] Unità Funzionale di Ematologia,Dipartimento di Area Critica
[2] Università degli Studi,undefined
[3] Istituto Toscano Tumori,undefined
[4] Unità di Epidemiologia Clinica-Centro per lo Studio della Mielofibrosi,undefined
[5] Fondazione IRCCS Policlinico San Matteo,undefined
来源：
Leukemia | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1533 / 1537
页数：4
相关论文
共 50 条
  • [31] THE ASSOCIATION BETWEEN JAK2 46/1 HAPLOTYPE AND SUSCEPTIBILITY TO MYELOPROLIFERATIVE NEOPLASMS
    Ouyang, J.
    Feng, X.
    Zhou, M.
    HAEMATOLOGICA, 2013, 98 : 625 - 625
  • [32] Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
    Rumi, Elisa
    Pietra, Daniela
    Pascutto, Cristiana
    Guglielmelli, Paola
    Martinez-Trillos, Alejandra
    Casetti, Ilaria
    Colomer, Dolors
    Pieri, Lisa
    Pratcorona, Marta
    Rotunno, Giada
    Sant'Antonio, Emanuela
    Bellini, Marta
    Cavalloni, Chiara
    Mannarelli, Carmela
    Milanesi, Chiara
    Boveri, Emanuela
    Ferretti, Virginia
    Astori, Cesare
    Rosti, Vittorio
    Cervantes, Francisco
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    Cazzola, Mario
    BLOOD, 2014, 124 (07) : 1062 - 1069
  • [33] MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms
    M M Patnaik
    T L Lasho
    C M Finke
    N Gangat
    D Caramazza
    S Siragusa
    C A Hanson
    A Pardanani
    A Tefferi
    Leukemia, 2010, 24 : 859 - 860
  • [34] MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms
    Patnaik, M. M.
    Lasho, T. L.
    Finke, C. M.
    Gangat, N.
    Caramazza, D.
    Siragusa, S.
    Hanson, C. A.
    Pardanani, A.
    Tefferi, A.
    LEUKEMIA, 2010, 24 (04) : 859 - 860
  • [35] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Zhang, Xinju
    Hu, Tingting
    Wu, Zhiyuan
    Kang, Zhihua
    Liu, Weiwei
    Guan, Ming
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 611 - 616
  • [36] The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
    Jones, Amy V.
    Campbell, Peter J.
    Beer, Philip A.
    Schnittger, Susanne
    Vannucchi, Alessandro M.
    Zoi, Katerina
    Percy, Melanie J.
    McMullin, Mary Frances
    Scott, Linda M.
    Tapper, William
    Silver, Richard T.
    Oscier, David
    Harrison, Claire N.
    Grallert, Harald
    Kisialiou, Aliaksei
    Strike, Paul
    Chase, Andrew J.
    Green, Anthony R.
    Cross, Nicholas C. P.
    BLOOD, 2010, 115 (22) : 4517 - 4523
  • [37] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Xinju Zhang
    Tingting Hu
    Zhiyuan Wu
    Zhihua Kang
    Weiwei Liu
    Ming Guan
    International Journal of Hematology, 2012, 96 : 611 - 616
  • [38] The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations
    Cross, Nicholas C. P.
    Campbell, Peter
    Beer, Philip A.
    Schnittger, Susanne
    Vannucchi, Alessandro M.
    Zoi, Katerina
    Percy, Melanie
    McMullin, Mary Frances
    Scott, Linda
    Silver, Richard T.
    Oscier, David
    Harrison, Claire
    Green, Anthony R.
    Chase, Andrew
    BLOOD, 2009, 114 (22) : 180 - 180
  • [39] JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia
    H Andrikovics
    S Nahajevszky
    M Koszarska
    N Meggyesi
    A Bors
    G Halm
    S Lueff
    N Lovas
    Z Matrai
    J Csomor
    R Rasonyi
    M Egyed
    J Varkonyi
    G Mikala
    A Sipos
    A Kozma
    E Adam
    S Fekete
    T Masszi
    A Tordai
    Leukemia, 2010, 24 : 1809 - 1813
  • [40] JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia
    Andrikovics, H.
    Nahajevszky, S.
    Koszarska, M.
    Meggyesi, N.
    Bors, A.
    Halm, G.
    Lueff, S.
    Lovas, N.
    Matrai, Z.
    Csomor, J.
    Rasonyi, R.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Kozma, A.
    Adam, E.
    Fekete, S.
    Masszi, T.
    Tordai, A.
    LEUKEMIA, 2010, 24 (10) : 1809 - 1813
12345